SHIN NIPPON BIOMEDICAL Aktie

1,99 EUR -3,5420%

Zu Ihrem Onlinebroker

kaufen verkaufen

SHIN NIPPON BIOMEDICAL Aktienkurs : 08:05 ( 15 Min. verzögert)
1,99 € Letzter Kurs	-3,54% Veränderung	2,06 € Vortag	1,99 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
1,99 - 1,99 Tag	3,24 - 1,77 52 Wochen	0 Tag	0 Ø 52 Wochen	1,94 4.000 Stücke	1,99 4.000 Stücke

SHIN NIPPON BIOMEDICAL Aktien…

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

16.05.

SNBL invests in animal welfare at US lab

The firm – the US subsidiary of Japan's Shin Nippon Biomedical Laboratories – has added 'enrichment tunnels' that permit animals to be socially housed in groups of three or four in...
15.05.

SNBL USA Expands Its Social Housing Program

SNBL USA is a wholly owned subsidiary of Shin Nippon Biomedical Laboratories, Ltd. (SNBL), one of the largest CROs in Japan. With its multiple worldwide facilities and countless skilled and experienced...

15.05.

SNBL fixes probs at Everett lab; animal shipment blocked by Israeli courts

SNBL – the US subsidiary of Japanese CRO Shin Nippon Biomedical Laboratories – was issued with an US Food and Drug Administration (FDA) warning letter in August 2010 after the agency...
07.05.

SNBL CPC Implements Verified Clinical Trials Clinical Trials Database Registry ...

Shin Nippon Biomedical Laboratories (SNBL CPC), a leader in early clinical trial research services, has partnered with Verified Clinical Trials (VCT) to improve clinical research subject safety and d…
07.05.

SNBL CPC Implements Verified Clinical Trials Clinical Trials Database Registry ...

Shin Nippon Biomedical Laboratories (SNBL CPC), a leader in early clinical trial research services, has partnered with Verified Clinical Trials (VCT) to improve clinical research subject safety and d…